Concepedia

Vicky Makker

VM

Statistics

Publications

104

Citations

7.4K

H-Index

41

Active since

2008

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Eisai (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Hospital Clínico San Carlos

Vicky Makker is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and gynecologic oncology.

Publications per year

2008–2024

104

Publications

104

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

Funda Meric‐Bernstam, Vicky Makker, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 931 citations · Full text

Medicine, Oncology, Pharmacology +17

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Ana Oaknin, Tjalling Bosse, Carien L. Creutzberg et al. · Annals of Oncology · 2022 · 638 citations · Full text

Medicine, Gynecology, Oncology +15

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Vicky Makker, Matthew H. Taylor, Carol Aghajanian et al. · Journal of Clinical Oncology · 2020 · 522 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial

Vicky Makker, Drew Rasco, Nicholas J. Vogelzang et al. · The Lancet Oncology · 2019 · 480 citations · Full text

Medicine, Oncology, Pharmacology +6

Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors

Matthew H. Taylor, Chung‐Han Lee, Vicky Makker et al. · Journal of Clinical Oncology · 2020 · 456 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 104